Home › Triple-Negative Breast Cancer › Ohio › Akron
Triple-Negative Breast Cancer clinical trials in Akron, OH
3 studies for Triple-Negative Breast Cancer are looking for participants at sites in and around Akron (within about 30 miles). Open a study to see who can join and how to contact the study team.
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
RecruitingPhase 3
- Tri-County Hematology & Oncology Associates, Inc. ( Site 0076), Massillon · 20 mi away
- Cleveland Clinic - Mercy Hospital ( Site 0057), Canton · 21 mi away
A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer
RecruitingPhase 2
- Gabrail Cancer Center Research, Canton · 21 mi away
A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients
RecruitingPhase 3
- Gabrail Cancer Center, Canton · 21 mi away
Triple-Negative Breast Cancer trials in other cities
- Houston, TX41 studies
- New York City, NY31 studies
- Nashville, TN27 studies
- Los Angeles, CA27 studies
- Boston, MA26 studies
- San Antonio, TX23 studies
- Arlington, VA20 studies
- Atlanta, GA19 studies
- St. Louis, MO19 studies
- Dallas, TX18 studies
- Columbus, OH16 studies
- Chicago, IL16 studies
Other studies in Akron
- Non-Small Cell Lung Cancer22 studies
- Lung Cancer16 studies
- Cancer (all types)14 studies
- Breast Cancer13 studies
- Prostate Cancer9 studies
- Metastatic Cancer8 studies
- Colorectal Cancer8 studies
- Melanoma8 studies
- Acute Myeloid Leukemia8 studies
- Small Cell Lung Cancer8 studies
- Endometrial Cancer7 studies
- Steatotic Liver Disease7 studies
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.